Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Microenvironment”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Early research (Phase 1)Study completedNCT07477522
What this trial is testing

Effects of High-Fiber Diet on Gut Microbiota, Metabolism, and Immune Microenvironment in Solid Tumor Patients: A Clinical Study

Who this might be right for
Diet HabitsHigh-fibre DietSolid Tumor Cancer
West China Hospital 17
Not applicableWithdrawnNCT02599909
What this trial is testing

Gut Microbiota in People With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Cell Caricinoma+1 more
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT07808502
What this trial is testing

Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot UlcerDamp-Heat Toxins Accumulation Syndrome
Chengdu University of Traditional Chinese Medicine 120
Not applicableLooking for participantsNCT04567706
What this trial is testing

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Who this might be right for
Melanoma
Ohio State University Comprehensive Cancer Center 1,000
Testing effectiveness (Phase 2)WithdrawnNCT03661047
What this trial is testing

OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer

Who this might be right for
Colon Cancer
Massachusetts General Hospital
Not applicableStudy completedNCT04368468
What this trial is testing

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Who this might be right for
Triple Negative Breast Cancer
Institut Claudius Regaud 100
Not applicableLooking for participantsNCT03017573
What this trial is testing

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Who this might be right for
Ovarian CancerTriple-Negative Breast CancerHead and Neck Cancer+3 more
Institut Curie 1,050
Not applicableUnknownNCT05422547
What this trial is testing

Role of Immunoscore® in Stage II-III Colorectal Cancer

Who this might be right for
Colon Adenocarcinoma
D'Or Institute for Research and Education 100
Not applicableActive Not RecruitingNCT07564908
What this trial is testing

Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Neoplasms
Meng Qiu 64
Not applicableNot Yet RecruitingNCT06776198
What this trial is testing

Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

Who this might be right for
OsteosarcomaTranscriptomeTumor Microenvironment+1 more
Peking University People's Hospital 100
Not applicableStudy completedNCT03267641
What this trial is testing

Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 86
Not applicableLooking for participantsNCT07064330
What this trial is testing

Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Instituto de Investigación Biomédica de Salamanca 30
Not applicableStudy completedNCT07631611
What this trial is testing

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

Who this might be right for
Solid TumorsMetastatic Cancer to LiverMetastatic Cancer to the Bone+5 more
Wenlong Zhong, MD 938
Not applicableLooking for participantsNCT07669493
What this trial is testing

Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study

Who this might be right for
MACE, Arrhythmia, Pericardial Effusion and Survival
Hebei Medical University Fourth Hospital 150
Not applicableUnknownNCT03846856
What this trial is testing

The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance

Who this might be right for
Ovarian Cancer
Hillel Yaffe Medical Center 40
Not applicableEnded earlyNCT04875871
What this trial is testing

Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors

Who this might be right for
Cancer
EBG MedAustron GmbH 13
Not applicableNot Yet RecruitingNCT07198802
What this trial is testing

Molecular Research on Predictive Efficacy and New Therapeutic Targets for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 600
Not applicableLooking for participantsNCT07427186
What this trial is testing

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer

Who this might be right for
Solid Cancers
Institut Claudius Regaud 600
Not applicableLooking for participantsNCT06084195
What this trial is testing

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

Who this might be right for
High Grade Serous Ovarian Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 120
Not applicableNot Yet RecruitingNCT07150598
What this trial is testing

Immune-Marker Platform for Patients With Advanced Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVNSCLC Non-small Cell Lung Cancer
Technische Universität Dresden 500
Next Page